Latest Studies on Brain-Health Nutraceuticals

A mixed cell-culture and mouse study found that Ahiflower oil, a plant-based omega-3 source, reduced markers of endothelial inflammation, blood lipids, and platelet clotting activity at levels comparable to fish oil.

The randomized, double-blind placebo-controlled study found laboratory safety markers remained within normal ranges across treatment and placebo groups.

In the ninth episode, Nicholas and Lana unpack several longevity launches making waves, and why regulatory clearance, novelty, and clinical data are 3 separate things brands shouldn't blur together.

A randomized, crossover trial found that ThymoDream, a standardized black cumin seed oil, raised endogenous melatonin levels and improved several sleep measures over 7 nights, with lower reported daytime sleepiness than synthetic melatonin.

Piping Rock Health Products has launched a 300-mg NMN gummy under its Vitafusion brand, arriving less than a year after the FDA reversed its position on whether the ingredient could legally be sold as a dietary supplement.

The Indian branded-ingredient supplier has closed a growth investment from NDude Labs to expand clinical research and establish a dedicated US commercial operation, reflecting investor interest in ingredient companies that lead with published data.

Built on Calanus Oil and ORIVO-verified fish oil, the concept targets brands seeking faster, differentiated omega-3 product development.

At the Future Nutra Innovation Summit, PLT Health's Steve Fink discusses joint, cognitive, and longevity nutrition explaining why "experiential longevity" is reshaping formulation strategy.